Gplaco Solutions

Global Pharmacovigilance Experts In an era of surging safety data and evolving global mandates, GPLACO SOLUTIONS provides the "Strategic Intelligence" required to navigate the complexities of the US FDA, EMA, PMDA, and MHRA landscapes. With over 18 years of cross-functional expertise, we deliver high-level safety governance that secures product lifecycles and ensures absolute inspection readiness. We bridge the gap between functional execution and expert advisory, providing Global Compliance Solutions tailored for Marketing Authorisation Holders (MAH), Sponsors, Affiliates, License Partners, and Distributors. Our Core Strategic Solutions: Global Safety Governance & SERM: Specialized expertise in Global Case Management for Clinical Trials and Post-Marketing studies. We provide end-to-end Global QMS development and implementation for ICSR management, exhaustive Literature Surveillance, and robust Benefit-Risk Assessment Methodologies (PBRER/DSUR). Signal Detection & Management: We implement proactive Signal Detection frameworks and QPPV oversight to identify and mitigate risks across global product portfolios and markets. Audit & Inspection Readiness: We lead Risk-Based Assessments (RBA) to build proactive GVP Audit programs. From Mock Inspections to CAPA management and PVQA governance, we ensure you stay ahead of global regulators. Strategic Risk Management: Expertise in developing and maintaining RMP/REMS strategies, managing the PSMF, and ensuring compliance through SDEA/PVA oversight and Vendor Outsourcing & Delivery Management. AI/ML Innovation: Validated pathways for Pharmacovigilance Automation, integrating AI into Safety Databases (Argus/ArisG) to optimize workflow without compromising regulatory trust. At GPLACO SOLUTIONS, we turn regulatory complexity into operational strength. Whether you are a US biotech entering the EU market or an established firm seeking to future-proof your systems, we provide the expert advisory necessary for global success.